Incorporating SGLT-2 Inhibitors into the Management of Patients with Type 2 Diabetes

Incorporating SGLT-2 Inhibitors into the Management of Patients with Type 2 Diabetes

Live! Complimentary, Online Continuing Medical Education

LIVE ONLINE: Watch top diabetes specialists discuss using SGLT2 inhibitors to improve glycemic control live via streaming video, participate in real-time Q&A online and earn AMA PRA Category 1 CreditsTM. All session are complimentary, conveniently held online and approved for AMA PRA Category 1 Credit™.

Topics include:

• Clinical gaps in effective management of patients with type 2 diabetes and cardiovascular comorbidities
• The mechanism by which SGLT2 inhibitors improve glycemic control
• Compelling data supporting the efficacy of SGLT2 inhibitors in managing hyperglycemia
• Evidence of reduction in comorbid cardiovascular risk by SGLT2 inhibitor therapy
• Side effect profiles of SGLT2 inhibitors

Thursday, February 12, 2015

12:00 PM Incorporating SGLT-2 Inhibitors into the Management of Patients with Type 2 Diabetes

• Mark W. Stolar, MD, Feinberg School of Medicine, Northwestern University
• Richard Beaser, MD, Harvard Medical School